Compounds > n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Hibernation, Myocardial

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Hibernation, Myocardial in 2 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kodani, E1
Xuan, YT2
Shinmura, K2
Takano, H2
Tang, XL2
Bolli, R2
Wang, Y1
Liu, SQ1
Bhatnagar, A1

Other Studies

2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Hibernation, Myocardial

ArticleYear
Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 283, Issue:5

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzamides; Benzylidene Compounds; Celecoxib; Consciousness;

2002
Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Aug-29, Volume: 97, Issue:18

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyc

2000